Two standards in the Sarbanes-Oxley Act (which is mostly applicable to for profit corporations), cover non-profit corporations: document destruction and whistle-blower protection. The Heart Rhythm Society's Board of Trustees approved the below Whistle-Blower/Code of Conduct Policy in June 2009.



In 1979, four electrophysiologists recognized the need for a society dedicated to the field cardiac pacing and electrophysiology. Doctors J. Warren Harthorne, Victor Parsonnet, Seymour Furman, and Dryden Morse thus founded the North American Society of Pacing and Electrophysiology, or NASPE, in Boston. In 2004, NASPE celebrated its 25th anniversary, moved to Washington, DC and changes its name to Heart Rhythm Society (HRS) to better reflect its membership constituencies and expanded mission. 


This free 30 minute presentation will cover the spectrum of rhythm control strategies with focused topics, including the recent update to the AF Guidelines, pharmacological treatment options, and the latest thinking on rate vs. rhythm control. A case-based format will be utilized to demonstrate clinical decision pathways and the pros and cons of various therapeutic options, including FDA-approved antiarrhythmic agents.

WASHINGTON, DC — The U.S. Food and Drug Administration, in collaboration with major implantable pacemaker and ICD manufacturers, demonstrated the effects of emissions from radio frequency identification (RFID) readers on common implantable cardiac devices. According to research published in the January edition of the HeartRhythm Journal, the official journal of the Heart Rhythm Society, the observed effects may cause increasing complications as RFID use expands in the medical device field.

WASHINGTON, DC — New multicenter research reveals that female patients fail ablation procedures more often than male patients, according to a study published in the February edition of the HeartRhythm Journal, the official journal of the Heat Rhythm Society. The study also shows that males undergo catheter ablation for the treatment of atrial fibrillation five times as often as females and typically with significantly fewer complications.

The expert faculty present multiple cases to support their management advice and invite registrants to participate in the Live Questions and Answers session on Tuesday, June 11, 2013 from 7:30 - 8:30 p.m. ET.  We anticipate this innovative and interactive learning format will be a valuable educational tool for the electrophysiology community.

WASHINGTON, DC — March 1, 2010 – Analysis of ICD patients enrolled in four different trials found patients with life-threatening ventricular arrhythmias (VA) treated only with antitachycardia pacing (ATP) have higher survival rates than VA patients who experienced at least one shock-treated episode. According to research published in the March edition of the HeartRhythm Journal, the official journal of the Heart Rhythm Society, 80.2% of VA episodes were successfully treated with ATP-only therapy from an ICD.